Actin Filament Polymerization Regulates Gliding Motility by Apicomplexan Parasites<sup><a href="#FN182" rid="FN182" class=" fn">V⃞</a></sup>
Abstract
Host cell entry by Toxoplasma gondii depends critically on actin filaments in the parasite, yet paradoxically, its actin is almost exclusively monomeric. In contrast to the absence of stable filaments in conventional samples, rapid-freeze electron microscopy revealed that actin filaments were formed beneath the plasma membrane of gliding parasites. To investigate the role of actin filaments in motility, we treated parasites with the filament-stabilizing drug jasplakinolide (JAS) and monitored the distribution of actin in live and fixed cells using yellow fluorescent protein (YFP)-actin. JAS treatment caused YFP-actin to redistribute to the apical and posterior ends, where filaments formed a spiral pattern subtending the plasma membrane. Although previous studies have suggested that JAS induces rigor, videomicroscopy demonstrated that JAS treatment increased the rate of parasite gliding by approximately threefold, indicating that filaments are rate limiting for motility. However, JAS also frequently reversed the normal direction of motility, disrupting forward migration and cell entry. Consistent with this alteration, subcortical filaments in JAS-treated parasites occurred in tangled plaques as opposed to the straight, roughly parallel orientation observed in control cells. These studies reveal that precisely controlled polymerization of actin filaments imparts the correct timing, duration, and directionality of gliding motility in the Apicomplexa.
ACKNOWLEDGMENTS
We thank John Cooper, Daniel Goldberg, Dorothy Schaffer, and Wandy Beatty for helpful comments and critical review of this manuscript; Gary Ward (University of Vermont) for antibodies to IMC-1; Dominique Soldati (Imperial College of London) for the TgMyoA-GFP–expressing parasites; Naomi Morrissette for assistance with microscopy; and Robyn Roth and John Heuser for performing the freeze-fracture EM. Supported by the National Institutes of Health (NIH) (AI34036) (L.D.S.), the Burroughs Wellcome Fund (L.D.S.), NIH Institutional Training Grants AI017172–19 and T32 GM07200 (D.M.W.), and the Swedish Research Council (S.H.).
Footnotes
Online version of this article contains video material. Online version is available at www.molbiolcell.org .
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02–08–0458. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02–08–0458.




